Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab in uncontrolled asthma (MESOS)
NCT02449473Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2015
- Primary completion
- Jun 2017
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of tralokinumab in asthma, sponsored by AstraZeneca. Started Sep 2015; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02449473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449473.